| Literature DB >> 31216904 |
Yulin Liang1, Xiaofei Zhang2, Junbo Zou2, Yajun Shi2, Yu Wang1, Jia Tai1, Yanjun Yang1, Xiao Zhou1, Dongyan Guo2, Jing Wang2, Jiangxue Cheng2, Ming Yang3.
Abstract
Chinese herbs such as Flos magnoliae (FM) and Centipeda minima (CM) can be effective in treating allergic rhinitis (AR). However, there is little research on the therapeutic mechanism of these two drugs acting on AR at the same time. In order to systematically understand the mechanism of action of two drugs acting on AR at the same time, we searched various databases to obtain 31 components and 289 target proteins of FM, 25 components and 465 target proteins of CM. The interaction networks of FM, CM, and AR proteins were constructed by Cytoscape-v3.2.1 software. The core protein of two network intersections was obtained by using Venny 2.1.0. The R platform was used for the core target protein gene ontology (GO) comment analysis and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis. Thirteen common targets and seven acting pathways were obtained. The results of animal experiments showed that FM and CM volatile oil could effectively improve the symptoms of AR by regulating the common targets. In summary, this study successfully explained the potential therapeutic mechanism of FM and CM in the treatment of AR. At the same time, it indicates that the two drugs can be compatible as a new application.Entities:
Keywords: allergic rhinitis; network pharmacology; pathway enrichment
Year: 2019 PMID: 31216904 DOI: 10.1080/03639045.2019.1635150
Source DB: PubMed Journal: Drug Dev Ind Pharm ISSN: 0363-9045 Impact factor: 3.225